Literature DB >> 26311880

Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.

Heather M Machkovech1, Trevor Bedford2, Marc A Suchard3, Jesse D Bloom4.   

Abstract

UNLABELLED: Numerous experimental studies have demonstrated that CD8(+) T cells contribute to immunity against influenza by limiting viral replication. It is therefore surprising that rigorous statistical tests have failed to find evidence of positive selection in the epitopes targeted by CD8(+) T cells. Here we use a novel computational approach to test for selection in CD8(+) T-cell epitopes. We define all epitopes in the nucleoprotein (NP) and matrix protein (M1) with experimentally identified human CD8(+) T-cell responses and then compare the evolution of these epitopes in parallel lineages of human and swine influenza viruses that have been diverging since roughly 1918. We find a significant enrichment of substitutions that alter human CD8(+) T-cell epitopes in NP of human versus swine influenza virus, consistent with the idea that these epitopes are under positive selection. Furthermore, we show that epitope-altering substitutions in human influenza virus NP are enriched on the trunk versus the branches of the phylogenetic tree, indicating that viruses that acquire these mutations have a selective advantage. However, even in human influenza virus NP, sites in T-cell epitopes evolve more slowly than do nonepitope sites, presumably because these epitopes are under stronger inherent functional constraint. Overall, our work demonstrates that there is clear selection from CD8(+) T cells in human influenza virus NP and illustrates how comparative analyses of viral lineages from different hosts can identify positive selection that is otherwise obscured by strong functional constraint. IMPORTANCE: There is a strong interest in correlates of anti-influenza immunity that are protective against diverse virus strains. CD8(+) T cells provide such broad immunity, since they target conserved viral proteins. An important question is whether T-cell immunity is sufficiently strong to drive influenza virus evolution. Although many studies have shown that T cells limit viral replication in animal models and are associated with decreased symptoms in humans, no studies have proven with statistical significance that influenza virus evolves under positive selection to escape T cells. Here we use comparisons of human and swine influenza viruses to rigorously demonstrate that human influenza virus evolves under pressure to fix mutations in the nucleoprotein that promote escape from T cells. We further show that viruses with these mutations have a selective advantage since they are preferentially located on the "trunk" of the phylogenetic tree. Overall, our results show that CD8(+) T cells targeting nucleoprotein play an important role in shaping influenza virus evolution.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26311880      PMCID: PMC4645657          DOI: 10.1128/JVI.01571-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Not so different after all: a comparison of methods for detecting amino acid sites under selection.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2005-02-09       Impact factor: 16.240

2.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

Review 3.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses.

Authors:  Jonathan W Yewdell
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

4.  Mechanism of protective immunity against influenza virus infection in mice without antibodies.

Authors:  S L Epstein; C Y Lo; J A Misplon; J R Bennink
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

5.  MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL.

Authors:  Y Deng; J W Yewdell; L C Eisenlohr; J R Bennink
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

Review 6.  Evolution of MHC class I genes in higher primates.

Authors:  K Lienert; P Parham
Journal:  Immunol Cell Biol       Date:  1996-08       Impact factor: 5.126

7.  Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States.

Authors:  Amy L Vincent; Kelly M Lager; Wenjun Ma; Porntippa Lekcharoensuk; Marie R Gramer; Christina Loiacono; Juergen A Richt
Journal:  Vet Microbiol       Date:  2006-08-01       Impact factor: 3.293

8.  Positive selection on the H3 hemagglutinin gene of human influenza virus A.

Authors:  R M Bush; W M Fitch; C A Bender; N J Cox
Journal:  Mol Biol Evol       Date:  1999-11       Impact factor: 16.240

9.  Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Authors:  E G M Berkhoff; E de Wit; M M Geelhoed-Mieras; A C M Boon; J Symons; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  The genomic sequence and analysis of the swine major histocompatibility complex.

Authors:  C Renard; E Hart; H Sehra; H Beasley; P Coggill; K Howe; J Harrow; J Gilbert; S Sims; J Rogers; A Ando; A Shigenari; T Shiina; H Inoko; P Chardon; S Beck
Journal:  Genomics       Date:  2006-03-02       Impact factor: 5.736

View more
  25 in total

1.  Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.

Authors:  Daniil A Korenkov; Karen L Laurie; Patrick C Reading; Louise A Carolan; Kok Fei Chan; Irina I Isakova-Sivak; Tatiana A Smolonogina; Kanta Subbarao; Ian G Barr; Julie Villanueva; Svetlana Shcherbik; Tatiana Bousse; Larisa G Rudenko
Journal:  Infect Genet Evol       Date:  2018-06-19       Impact factor: 3.342

2.  Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.

Authors:  Irina Isakova-Sivak; Daniil Korenkov; Tatiana Smolonogina; Tatiana Tretiak; Svetlana Donina; Andrey Rekstin; Anatoly Naykhin; Svetlana Shcherbik; Nicholas Pearce; Li-Mei Chen; Tatiana Bousse; Larisa Rudenko
Journal:  Virology       Date:  2016-11-06       Impact factor: 3.616

3.  Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections.

Authors:  D Korenkov; T H O Nguyen; I Isakova-Sivak; T Smolonogina; L E Brown; K Kedzierska; L Rudenko
Journal:  Hum Vaccin Immunother       Date:  2018-01-23       Impact factor: 3.452

Review 4.  Population Diversity and Collective Interactions during Influenza Virus Infection.

Authors:  Christopher B Brooke
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

5.  A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.

Authors:  Sergio M Quiñones-Parra; E Bridie Clemens; Zhongfang Wang; Hayley A Croom; Lukasz Kedzierski; Jodie McVernon; Dhanasekaran Vijaykrishna; Katherine Kedzierska
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

6.  Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Martina M Geelhoed-Mieras; Nella J Nieuwkoop; Monique I Spronken; David A M C van de Vijver; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

7.  Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.

Authors:  Andrey Rekstin; Irina Isakova-Sivak; Galina Petukhova; Daniil Korenkov; Igor Losev; Tatiana Smolonogina; Tatiana Tretiak; Svetlana Donina; Svetlana Shcherbik; Tatiana Bousse; Larisa Rudenko
Journal:  Biomed Res Int       Date:  2017-01-22       Impact factor: 3.411

8.  Deep mutational scanning identifies sites in influenza nucleoprotein that affect viral inhibition by MxA.

Authors:  Orr Ashenberg; Jai Padmakumar; Michael B Doud; Jesse D Bloom
Journal:  PLoS Pathog       Date:  2017-03-27       Impact factor: 6.823

9.  Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.

Authors:  Jiwon Jung; Sophia T Mundle; Irina V Ustyugova; Andrew P Horton; Daniel R Boutz; Svetlana Pougatcheva; Ponraj Prabakaran; Jonathan R McDaniel; Gregory R King; Daechan Park; Maria D Person; Congxi Ye; Bing Tan; Yuri Tanno; Jin Eyun Kim; Nicholas C Curtis; Joshua DiNapoli; Simon Delagrave; Ted M Ross; Gregory C Ippolito; Harry Kleanthous; Jiwon Lee; George Georgiou
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

10.  Red Queen Processes Drive Positive Selection on Major Histocompatibility Complex (MHC) Genes.

Authors:  Maciej Jan Ejsmond; Jacek Radwan
Journal:  PLoS Comput Biol       Date:  2015-11-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.